• 1. 519. The synthesis of thyroxine and related compounds. Part XVI. The preparation of 3,5-dichloro-D-thyronine: an unexpected Walden inversion
  W. K. Warburton J. Chem. Soc. 1961 2651
• 2. Index of subjects
  J. Chem. Soc. Abstr. 1911 100 ii1297
• 3. 625. Di-p-(2-amino-2-carboxyethyl)phenyl peroxide: preparation from tyrosine and probable natural occurrence in proteins
  J. W. Davies,G. Harris J. Chem. Soc. 1961 3193
• 4. Verification of exposure to chemical warfare agents through analysis of persistent biomarkers in plants
  Mirjam de Bruin-Hoegée,Latifa Lamriti,Jan P. Langenberg,René C. M. Olivier,Lai Fun Chau,Marcel J. van der Schans,Daan Noort,Arian C. van Asten Anal. Methods 2023 15 142
• 5. Natural products from myxobacteria: novel metabolites and bioactivities
  J. Herrmann,A. Abou Fayad,R. Müller Nat. Prod. Rep. 2017 34 135

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Tyrosine and derivatives
• Solvents and Organic Chemicals Organic Compounds Acids/Esters

Professional Introduction to 3,5-Dichloro-L-tyrosine (CAS No. 15106-62-4)

3,5-Dichloro-L-tyrosine, with the chemical formula C?H?Cl?NO?, is a halogenated derivative of the essential amino acid L-tyrosine. This compound has garnered significant attention in the field of pharmaceutical chemistry and biochemistry due to its unique structural properties and potential biological activities. As a CAS No. 15106-62-4 registered compound, it serves as a valuable intermediate in synthetic chemistry and a subject of interest in drug discovery programs.

The introduction of chlorine atoms at the 3rd and 5th positions of the tyrosine backbone enhances its reactivity, making it a versatile building block for designing novel molecules. The 3,5-dichloro-L-tyrosine structure is particularly intriguing because it combines the aromaticity and chiral properties of tyrosine with the electrophilic nature of chlorine substituents. This dual functionality has opened up new avenues for exploring its applications in medicinal chemistry.

In recent years, researchers have been exploring the pharmacological potential of halogenated tyrosine derivatives. The presence of chlorine atoms increases the lipophilicity of the molecule, which can improve its membrane permeability and binding affinity to biological targets. This feature has made 3,5-dichloro-L-tyrosine a promising candidate for developing small-molecule drugs targeting various diseases.

One of the most compelling areas of research involving 3,5-dichloro-L-tyrosine is its role in enzyme inhibition. Studies have shown that halogenated tyrosines can act as potent inhibitors of certain enzymes by mimicking the natural substrate or by forming covalent bonds with key residues in the active site. For instance, researchers have investigated its interaction with tyrosine kinases, which are overexpressed in many cancers. The chlorine atoms in 3,5-dichloro-L-tyrosine facilitate hydrophobic interactions and electrostatic repulsion, enhancing its binding affinity to these enzymes.

Furthermore, the chiral nature of L-tyrosine ensures that 3,5-dichloro-L-tyrosine exists as a single enantiomer, which is crucial for drug development. Enantiomeric purity is essential for achieving optimal pharmacological effects while minimizing side reactions. The stereochemical integrity of this compound has made it an attractive scaffold for designing enantiopure drugs with improved therapeutic profiles.

Recent advancements in computational chemistry have also contributed to the study of 3,5-dichloro-L-tyrosine. Molecular docking simulations have been employed to predict its binding modes with various biological targets, including proteases and receptors. These simulations have provided insights into how the chlorine substituents influence the molecule's interactions with proteins, guiding the design of more effective derivatives.

The synthetic pathways for producing 3,5-dichloro-L-tyrosine have also seen significant developments. Modern synthetic methods focus on improving yield and purity while reducing environmental impact. Catalytic chlorination techniques have been particularly useful in introducing chlorine atoms at specific positions without affecting other functional groups. These advancements have made large-scale production of 3,5-dichloro-L-tyrosine more feasible for industrial applications.

In conclusion, 3,5-Dichloro-L-tyrosine (CAS No. 15106-62-4) represents a fascinating compound with diverse applications in pharmaceutical research. Its unique structural features and biological activities make it a valuable tool for drug discovery and development. As research continues to uncover new therapeutic potentials, this compound is likely to play an increasingly important role in addressing various medical challenges.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)